Stocks and Investing
Stocks and Investing
Mon, March 4, 2024
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
Jamie Perse Maintained (UHS) at Strong Buy with Increased Target to $189 on, Mar 4th, 2024
Jamie Perse of Goldman Sachs, Maintained "Universal Health Services, Inc." (UHS) at Strong Buy with Increased Target from $170 to $189 on, Mar 4th, 2024.
Jamie has made no other calls on UHS in the last 4 months.
There are 6 other peers that have a rating on UHS. Out of the 6 peers that are also analyzing UHS, 3 agree with Jamie's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Gary Taylor of "TD Cowen" Maintained at Hold with Increased Target to $181 on, Friday, March 1st, 2024
- Andrew Mok of "UBS" Maintained at Hold with Increased Target to $177 on, Thursday, February 29th, 2024
- Calvin Sternick of "JP Morgan" Maintained at Hold with Decreased Target to $144 on, Friday, November 17th, 2023
These are the ratings of the 3 analyists that currently disagree with Jamie
- Jason Cassorla of "Citigroup" Maintained at Strong Buy with Increased Target to $193 on, Thursday, February 29th, 2024
- Sarah James of "Cantor Fitzgerald" Maintained at Sell with Increased Target to $156 on, Thursday, February 29th, 2024
- Stephen Baxter of "Wells Fargo" Upgraded from Hold to Buy and Held Target at $177 on, Tuesday, January 2nd, 2024
Contributing Sources